Parabolic Drugs (Delisted) share price

BSE: 533211Pharmaceuticals & Biotechnology

Parabolic Drugs Ltd · Face value ₹10 · Listed Jul 2010

Last traded ₹5.50 on 25 Jan 2021

Delisted on 11 Aug 2021.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.

  1. Aug 2021

    • 4 Aug · Voluntary Delisting

      Members of the Exchange are hereby informed that the admission to dealings in securities of Parabolic Drugs Limited shall be withdrawn (delisted) w.e.f. August 11, 2021 Pursuant to Resolution plan Approved by Hon'ble National Company Law Tribunal (NCLT) Under Section 31 of the Insolvency and Bankruptcy Code (IBC), 2016."
  2. Feb 2021

Share price history

Daily closes since Jul 2010, BSE closes in Jul 2010, in Jan 2019, in Feb 2019 and in Apr 2019, adjusted for splits and bonuses

Daily close, ₹ per share

Results for the quarter to Jun 2020

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Parabolic Drugs results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2020. Results for the quarter to Sep 2020 were due by 14 Nov 2020, 45 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss
24−14Sep 1716−15Dec 1716−14Mar 1813−11Jun 185.0−14Sep 180.3−7.1Dec 180−8.3Mar 190−7.8Jun 19Sep 19Dec 190−7.2Mar 20Jun 20
Peak revenue ₹24 Cr, quarter to Sep 2017; lowest ₹0.00 Cr, quarter to Mar 2019A loss in 9 of the 9 quarters with results on record

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
−15.3%−2,726.9%−15.3%−27.5%−19.3%−37.8%−119.1%−773.1%−59.4%−94.4%−87.9%−81.9%−288.5%−2,726.9%Sep 17Mar 18Sep 18Mar 19Sep 19Mar 20Jun 20
₹ croreSep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Q1Sep 2018Dec 2018Q3Mar 2019Jun 2019Q1Sep 2019Dec 2019Mar 2020Jun 2020
Revenue from operations2021141116282215241616135000––0–
7815593431627–212821191811222––2–
Materials and goods bought701466638920−2514211514128000––0–
Employee costs332––––223112111––0–
Other expenses5724––––454451101––1–
Operating profit before depreciation−58−135−79−3201–−5−4−5−3−5−6−2−2−2––−2–
Operating margin−295.1%−654.9%−584.2%−287.4%0.9%4.5%–−35.5%−15.3%−27.5%−19.3%−37.8%−119.1%−773.1%––––––
Depreciation and amortisation171716131313−13999966556––5–
Other income–––––––400001000––0–
Finance costs272728322833833222130−10––0–
Profit before one-off items and tax−102−179−123−77−42−4558−12−14−15−14−12−14−7−7−8––−7–
One-off items–––––––––––000−20––0–
Profit before tax−102−179−123−77−42−4558−12−14−15−14−12−14−7−9−8––−7–
––4–21–0000−11000––0–
Net profit−102−179−128−77−43−4558−13−14−15−14−11−14−7−8−8––−7–
Net margin−516.3%−869.7%−942.1%−693.4%−262.6%−161.7%258.4%−82.3%−59.4%−94.4%−87.9%−81.9%−288.5%−2,726.9%––––––
Earnings per share–––––−₹7.33₹9.33−₹2.04−₹2.30−₹2.50−₹2.37−₹3.40−₹2.32−₹5.17−₹1.40−₹2.40––−₹1.17–
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarters to Sep 2019 and Dec 2019. The quarter to Jun 2020 is not shown: its results were filed at the wrong scale, a power of ten off the company's own year-to-date figures.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
63553Mar 1192851Mar 12769−140Mar 13451−132Mar 14233−379Mar 1576−485Mar 1678−108Mar 1773−57Mar 1818−41985Mar 190−29156Mar 20
Peak revenue ₹928 Cr, year to Mar 2012; lowest ₹0.00 Cr, year to Mar 2020A loss in 8 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
8.3%−639.2%−9.1%−15.3%−33.2%−403.3%−53.4%−22.1%−81.6%8.3%5.5%−18.2%−29.2%−162.8%−639.2%−138.6%−77.9%−224.8%Mar 11Mar 13Mar 15Mar 17Mar 19Mar 20

Results for the year to Mar 2020

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs−1.7
  3. Other expenses−4.7
  4. Operating profit−6.4
  5. Depreciation−22
  6. Other income0.0
  7. One-off items0.0
  8. Finance costs−0.7
  9. Profit before tax−29
  10. Tax0.0
  11. Net profit−29

What the company owns

  • Plant, investments and other assets₹320 Cr
  • Receivables₹27 Cr
  • Inventory₹1 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Other liabilities₹192 Cr
  • Borrowings₹156 Cr

Profit and loss

Standalone, ₹ crore, years to March.

₹ croreMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue from operations635928769451233767873180
––83951931038212089336
Materials and goods bought4516967693692563299263200
Employee costs––221917118952
Other expenses––491323843191685
Operating profit before depreciation––−70−69−77−306−42−16−15−6
Operating margin––−9.1%−15.3%−33.2%−403.3%−53.4%−22.1%−81.6%–
Materials, % of revenue––100.0%81.9%109.8%432.8%117.9%87.5%110.6%–
Employee costs, % of revenue––2.8%4.1%7.3%14.1%10.9%12.2%29.5%–
Other expenses, % of revenue––6.3%29.2%16.1%56.4%24.6%22.4%41.5%–
Depreciation and amortisation––5568736753352222
Operating profit after depreciation––−125−137−150−373−95−51−37−28
Other income–––––––410
Finance costs416470839910810831
Profit before one-off items and tax6966−195−220−249−481−105−55−39−29
One-off items––––––––−20
Profit before tax6966−195−220−249−481−105−55−41−29
1615−55−6113043200
Net profit5351−140−132−379−485−108−57−41−29
Net margin8.3%5.5%−18.2%−29.2%−162.8%−639.2%−138.6%−77.9%−224.8%–
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2011 and Mar 2012: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020
−887−916
Share capital6262
Reserves−949−978
985156
393398
867867
Total assets372348
312290
6059
Net debt984156
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2011, Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Earnings per share₹9.43₹8.27−₹22.58−₹21.29––−₹17.46−₹9.21−₹6.57−₹4.63
Diluted earnings per share₹9.43₹8.27−₹22.58−₹21.29––−₹17.46−₹9.21−₹6.57−₹4.63
Book value per share––––––––−₹143.32−₹148.06
Market cap at the year end (₹ crore)2651803927––53–107

Ratios

Standalone, years to March.

RatioMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue growth22.4%46.2%−17.2%−41.4%−48.3%−67.4%2.7%−6.9%−75.1%−100.0%
Net profit growth54.6%−3.1%––––––––
Earnings per share growth−47.4%−12.3%––––––––
Return on equity––––––––4.6%–
Return on capital employed––––––––−37.4%–
Receivable days––––––––562–
Inventory days––––––––12–
Payable days––––––––1,325–
Cash conversion cycle, days––––––––−751–
Working capital days––––––––−3,645–
Asset turnover––––––––0.050.00
Assets per rupee of net worth––––––––−0.42−0.40
Sales per rupee of plant––––––––0.060.00
Plant being built, % of plant in use––––––––2.2%2.4%
Interest cover is left blank for the years to Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017, Mar 2018, Mar 2019 and Mar 2020: operating profit after depreciation is a loss, and a loss covers no interest bill. Debt to equity is left blank for the years to Mar 2019 and Mar 2020: net worth is below zero, so there is no shareholders' money to set the borrowings against. Return on capital employed is left blank for the year to Mar 2020: net worth and borrowings together come to nought or less, so there is no money employed to set the operating profit against. No balance sheet is on record for the years to Mar 2011, Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2020.

Return on assets, latest year
−7.9%
Measure10 years5 years3 years
Operating margin, average–−140.1%−51.8%
Net margin, average−141.9%−270.1%−151.4%
Asset turnover, average––0.02

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Altman Z-scorePublished threshold 1.81––––––––−4.92−5.36
Receivables growth less revenue growthOur threshold 0 percentage points–––––––––97.84
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––––––––100.00
Assets under construction, years of additionsOur threshold 2 years of additions–––––––––10.35
Effective tax ratePublished threshold 17.16 per cent23.0222.92––––––––
A threshold marked as ours has no published figure; it is the line we read the check against.

Business segments

In the year to Mar 2020 the company reports one business segment, PHARMACEUTICALS, which carries all its revenue.

Where the return came from

Yearly rates to Mar 2020, per-share figures restated for splits and bonuses.

OverReturn a yearEarnings growthChange in P/EDividend yield
1 year−28.1%––0.0%
3 years−48.7%––0.0%
5 years−33.4%––0.0%
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.

Parabolic Drugs share price by year

Each calendar year to 2021.

YearClose at year endChangeHighest closeLowest close
20215.50+8.9%6.355.30
20205.05+68.3%5.050.70
2019BSE close3.00+15.4%3.900.50
20182.60−69.4%8.952.50
20178.50+6.3%11.356.10
20168.00−13.0%10.903.85
20159.20+4.0%15.007.05
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2021 close is its last trade, on 25 Jan 2021.

Recent sessions

The 10 trading days to 25 Jan 2021, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
25 Jan 20215.505.505.505.505.50123
18 Jan 20215.755.755.755.755.7548,033
8 Jan 20216.656.656.056.056.441,31,992
7 Jan 20216.356.356.356.356.3510,098
6 Jan 20216.056.056.056.056.058,339
5 Jan 20215.805.805.805.805.8060,912
4 Jan 20215.555.555.555.555.5522,364
1 Jan 20215.305.305.305.305.308,665
31 Dec 20205.055.055.055.055.054,403
30 Dec 20204.854.854.854.854.8514,651
Prices in ₹ per share as traded, not adjusted.

Company details

BSE code
533211
ISIN
INE618H01016
Industry
Pharmaceuticals & Biotechnology
Former symbols
PARABDRUGS
CIN
L24231CH1996PLC017755
Corporate identity number, the registrar of companies' code for it
Incorporated
1996
Registered office
S.C.O. 186-187, 2nd Floor, Sector 8C, Chandigarh 160017, Chandigarh
Share registrar
Link Intime India Pvt. Ltd
Keeps the register of shareholders and handles transfers and dividend payments